Owl Posting
essays about biology and ml, written for and by owls. Click to read Owl Posting, by Abhishaike Mahajan, a Substack publication with tens of thousands of subscribers.
- Posts
- 92 from 8 Mar 2024 to 21 Sep 2026
- Posting
- weekly (27 in the last year)
- Kind
- personal blog
- Feed
- https://www.owlposting.com/feed
2026 20
- Are organoids useful for Alzheimer’s research?
- Where have organoids actually been useful?
- Why haven't organoids solved all of drug discovery?
- How to design a cancer vaccine (and vastly improve them): Alex Rubinsteyn & Ben Vincent
- The makings of a good bioweapon
- How to build a cancer vaccine, and whether they will work this time
- The ballad of TIGIT
- How financial architectures shaped (and will continue to shape) Chinese drug development
- Perturb-MARS: Reading mouse experiments through a human lens
- Curious cases of financial engineering in biotech
- The printing press for biological data (Sterling Hooten)
- On creating 'new knobs of control' in biology
- Owl Posting turns two
- Reasons to be pessimistic (and optimistic) on the future of biosecurity
- Neurotechnology? For Cancer? (Ben Woodington & Elise Jenkins)
- Heuristics for lab robotics, and where its future may go
- AI After Drug Development
- Questions to ask when evaluating neurotech approaches
- The truth behind the 2026 J.P. Morgan Healthcare Conference
- A 2026 look at three bio-ML opinions I had in 2024
2025 40
- The origin of rot
- The ML drug discovery startup trying really, really hard to not cheat (Leash Bio)
- What if we could grow human tissue by recapitulating embryogenesis? (Matthew Osman & Fabio Boniolo)
- We don't know what most microbial genes do. Can genomic language models help? (Yunha Hwang, Ep #7)
- Human art in a post-AI world should be strange
- Bringing organ-scale cryopreservation into existence (Hunter Davis, Ep #6)
- Can machine learning enable 100-plex cryo-EM structure determination? (Ellen Zhong, Ep #5)
- Cancer has a surprising amount of detail
- The optimistic case for protein foundation model companies
- Ask not why would you work in biology, but rather: why wouldn't you?
- RNA structure prediction is hard. How much does that matter?
- How do you use a virtual cell to do something actually useful?
- A compilation of eleven stories
- The DNA protection company (Alan Tomusiak, Ep #4)
- A vibe check on the San Francisco biotech scene
- Mapping the off-target effects of every FDA-approved drug in existence (EvE Bio)
- Joining Noetik
- Comments on 'Endometriosis is an incredibly interesting disease'
- Endometriosis is an incredibly interesting disease
- Administering immunotherapy in the morning seems to really, really matter. Why?
- A body most amenable to experimentation
- Drugs currently in clinical trials will likely not be impacted by AI
- Will protein design tools solve the snake antivenom shortage?
- What could Alphafold 4 look like? (Sergey Ovchinnikov, Ep #3)
- On painful books
- A retrospective on writing a technical blog for a year
- What happened to pathology AI companies?
- Optogenetics could change the world. So why hasn’t it?
- Roundup #4 (Feb 23-Mar 15, 2025)
- Opinionated advice for writing about science
- A socratic dialogue over the utility of DNA language models (Part 2 of 2)
- Roundup #3 (announcements, links, jobs)
- A socratic dialogue over the utility of DNA language models (Part 1 of 2)
- AI-Designed Enzymes
- Roundup #2 (announcements, links, jobs)
- How do you make a 250x better vaccine at 1/10 the cost? Develop it in India. (Soham Sankaran, Ep #2)
- Reinforcement Learning by AI Punishment
- Roundup #1 (announcements, links, and jobs)
- Is there such a thing as an impossible protein?
- Better antibodies by engineering targets, not engineering antibodies (Nabla Bio)
2024 32
- A primer on machine learning in cryo-electron microscopy (cryo-EM)
- Can o1-preview find major mistakes amongst 59 NeurIPS '24 MLSB papers?
- A retrospective on filming a science podcast
- Can AI improve the current state of molecular simulation? (Corin & Ari Wagen, Ep #1)
- Why Recursion Pharmaceuticals abandoned cell painting for brightfield imaging
- Interesting links #3
- There aren't enough smart people in biology doing something boring
- Interesting links #2
- The unreasonable effectiveness of plasmid sequencing as a service (Plasmidsaurus)
- Models of Life
- Interesting links #1
- Generative ML in chemistry is bottlenecked by synthesis
- Fictional parasites very different from our own
- Things I learned talking to the new breed of scientific institution
- Creating the largest protein-protein interaction dataset in the world (A-Alpha Bio)
- A socratic dialogue over why drugs work at all
- A primer on the current state of longevity research
- Wet-lab innovations will lead the AI revolution in biology
- Scaling microbial metagenomic datasets (Basecamp Research)
- Why write about biotech startups?
- A primer on GFP and esmGFP
- Five things to keep in mind while reading biology ML papers
- A primer on why microbiome research is hard
- Molecular dynamics data will be essential for the next generation of ML protein models
- A primer on molecular dynamics
- Some of my favorite pessimistic scientific articles
- A primer on why computational predictive toxicology is hard
- A primer on the next generation of antibodies
- A primer on machine learning in antibody engineering
- Token:parameters in protein language models
- A primer on scRNA-seq foundation models
- RFDiffusion: (5) anecdotal observations over a year